Patent Pending · AU 2026901796 · GMP ISO 22716 · Australian Made

Australia's First
Cold-Process
Transdermal
Delivery Platform.

GlowSense is a GMP-certified cosmetic contract manufacturer in Ravenhall, Victoria — powered by the patent-pending One Pot Process (OPP) Method. We deliver heat-sensitive actives at 33–91× conventional penetration. Zero prior art worldwide.

GlowSense
Crafting Beauty. Creating Confidence.
Ravenhall VIC 3023 · glowsense.com.au
OPP Method — Peer-Reviewed Data
33×
In vitro porcine skin penetration vs passive control
72×
In vivo enhancement BALB/c mice (p<0.05)
62×
Dermis accumulation increase vs passive control
15×
Superior to Dermaroller microneedling in vivo
73.4%
Human dermal absorption rate (clinical trial, 2025)
Heat required — full ambient cold-process manufacture
Source: Zhang et al. (2017) Mol Pharmaceutics PMID 28763230 · PMC12564063 (2025)
Scroll
🏭
ISO 22716 GMP

Certified by SGS Australia

🔬
Patent Pending

AU 2026901796 · OPP Method

⚗️
RDTI Registered

43.5% refundable R&D offset

🌿
Cold-Process

Zero active degradation

🇦🇺
Made in Australia

Ravenhall VIC 3023

The One Pot Process
(OPP) Method

Standard cosmetic emulsification at 70–75°C destroys the actives that matter most — peptides, postbiotics, growth factors, Vitamin C derivatives, retinol and enzymatic actives are all denatured before the product reaches your consumer.


The One Pot Process is a patent-pending cold-process, single-vessel co-formulation technique. Marine bio-spicules from Haliclona sp. (oxea-type, 100–400 µm) are combined with actives at ambient temperature in one vessel. On skin application, spicules create transient microchannels in the stratum corneum for genuine sub-epidermal delivery.


Global prior art search across AU, US, EP, CN, KR and WO: zero prior art confirmed. Patent application AU 2026901796 filed 5 March 2026.

33×
In vitro porcine skin (FD-10)
62×
Dermis accumulation
72×
In vivo (BALB/c mice)
73.4%
Human dermal absorption
stratum corneum viable epidermis & dermis Haliclona sp. bio-spicule (~120µm) active active active active 33–91×
Single vessel · Ambient temperature · Bio-spicule + actives co-formulated simultaneously
What OPP Unlocks
Peptides & copper peptides preserved 100% intact
Live probiotics, postbiotics & prebiotic oligosaccharides
Vitamin C, Retinol, Astaxanthin, Bakuchiol, CoQ10
SOD, DNA repair enzymes, EGF & growth factor mimetics
Exosomes & MSC secretome (73.4% human dermal absorption)

OPP-Powered Products
That Actually Deliver

💆
GS-002-A
Night Recovery Scalp Serum

50ml · Triple Peptide 13.5% — Capixyl 6%, Matrixyl 3000 5%, Copper Tripeptide 2.5%. All heat-labile above 45°C. OPP delivers intact peptide complex to the hair follicle dermis.

OPPPeptide 13.5%Scalp
GS-003
Brightening Serum

30ml · Niacinamide 10% + Signal Peptide Complex cold-process co-formulated with bio-spicules. Sub-epidermal delivery for genuine brightening beyond surface diffusion.

OPPNiacinamide 10%Brightening
🌟
GS-004
Radiance Brightening Serum

30ml · SAP Vitamin C + Ferulic Acid + Alpha-Arbutin — cold-process preserves 100% SAP activity. OPP bio-spicule delivery reaches the fibroblast layer for collagen synthesis stimulation.

OPPSAP Vitamin CFerulic Acid

Why GlowSense Is
Categorically Different

— Other Australian Contract Manufacturers

Hot-process at 70–75°C degrades peptides, probiotics, Vitamin C and enzymatic actives before the product reaches your consumer
Delivery limited to stratum corneum surface — no transdermal penetration enhancement mechanism
No proprietary IP — any GMP competitor can replicate services identically, creating race-to-bottom pricing
Claims compete on concentration alone — "10% niacinamide" not actual epidermal bioavailability

✦  GlowSense One Pot Process Platform

Ambient-temperature manufacture — every heat-sensitive active delivered 100% intact from batch to shelf
33–91× peer-reviewed transdermal delivery enhancement via Haliclona sp. bio-spicule microchannels (PMID 28763230)
Patent-pending IP (AU 2026901796), zero global prior art — a technology moat no GMP certificate can replicate
Claims shift from concentration to delivery — "33× transdermal bioavailability" is a stronger market position for your brand

The Actives Your Consumers
Have Never Had Until Now

The OPP Method unlocks a full spectrum of heat-sensitive actives that conventional hot-process manufacturing cannot formulate without destroying.

🧬

Signal & Copper Peptides

Matrikine, neurotransmitter-inhibiting and copper peptide complexes. All denatured above 45–50°C. OPP delivers intact to dermis.

🦠

Prebiotics & Postbiotics

Ferment lysates, live probiotic cultures, inulin, FOS oligosaccharides. Enzyme activity destroyed above 37°C — only viable via cold-process.

☀️

Vitamins & Antioxidants

SAP, MAP, EAC, Retinol, Astaxanthin, Bakuchiol, Resveratrol, CoQ10. Oxidative degradation above 40°C eliminated by cold-process OPP.

⚗️

Enzymes & Growth Factors

SOD, Catalase, DNA repair enzymes, EGF mimetics, exosomes. Protein denaturation above 37–40°C — only viable via cold-process OPP.

Quality You Can
Independently Verify

ISO 22716

Cosmetics GMP

Certified by SGS Australia. Annual surveillance audit. Accepted for EU, UK, US and Asian export documentation.

RDTI

R&D Tax Incentive

Formally registered with ATO & AusIndustry. 43.5% refundable offset on eligible R&D. Adviser: RADBE Consulting.

AU PAT

Patent Pending

AU 2026901796. GlowSense Holdings Pty Ltd. Zero global prior art (6 jurisdictions). PCT filing March 2027.

IGP

Industry Growth Programme

Advisory Service approved IGPAS007206. Government recognition as advanced manufacturing business.

Seed Round Open · Closing 30 June 2026

AUD $500,000 · ESIC Eligible

We are raising AUD $500K to commercialise the OPP Method — Australia's first patent-pending cold-process transdermal delivery platform. Revenue-generating from day one. GMP operational. Zero global prior art confirmed.

ESIC Eligible GMP Operational RDTI Co-Investment PCT March 2027
Investor Information →

Ready to Manufacture
Something Better?

Send us your active brief. We respond within 48 hours. NDA signed before any technical discussion. MOQ from 500 units.